Download MendeleyGNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1.
Taylor, A.M., Bailey, C., Belmont, L.D., Campbell, R., Cantone, N., Cote, A., Crawford, T.D., Cummings, R., DeMent, K., Duplessis, M., Flynn, M., Good, A.C., Huang, H.R., Joshi, S., Leblanc, Y., Murray, J., Nasveschuk, C.G., Neiss, A., Poy, F., Romero, F.A., Sandy, P., Tang, Y., Tsui, V., Zawadzke, L., Sims 3rd, R.J., Audia, J.E., Bellon, S.F., Magnuson, S.R., Albrecht, B.K., Cochran, A.G.(2022) J Med Chem 65: 11177-11186
- PubMed: 35930799
- DOI: https://doi.org/10.1021/acs.jmedchem.2c00662
- Primary Citation of Related Structures:
7TAB, 7TD9 - PubMed Abstract:
Bromodomains are acetyllysine recognition domains present in a variety of human proteins. Bromodomains also bind small molecules that compete with acetyllysine, and therefore bromodomains have been targets for drug discovery efforts. Highly potent and selective ligands with good cellular permeability have been proposed as chemical probes for use in exploring the functions of many of the bromodomain proteins. We report here the discovery of a class of such inhibitors targeting the family VIII bromodomains of SMARCA2 (BRM) and SMARCA4 (BRG1), and PBRM1 (polybromo-1) bromodomain 5. We propose one example from this series, GNE-064, as a chemical probe for the bromodomains SMARCA2, SMARCA4, and PBRM1(5) with the potential for in vivo use.
Organizational Affiliation:
Constellation, a Morphosys Company, 215 First Street, Suite 200, Cambridge, Massachusetts 02142, United States.
